ArticleNano letters2025
Development of Chemical Tags for Universal Lipid Nanoparticle Visualization and Tracking in 2D and 3D Imaging.
Article in Nano letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lipid nanoparticles as active biointerfaces: From membrane interaction to systemic dysregulation.Acta pharmaceutica Sinica. B · 2026Review
- Current progress of labeling strategies in tissue clearing for large-scale biological visualization.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Precise delivery of therapeutic agents to specific cells and subcellular compartments is crucial for effective disease treatment. Lipid nanoparticles (LNPs) are promising drugs and gene nanocarriers, but understanding their transport within cells and tissues remains limited. We developed SPARKLE (Strategic Peptide, Anchored, Retained, and Kept after Lipid Elimination), a fluorescent peptide tag designed to track LNPs with advanced optical imaging techniques that involve lipid disruption (e.g., cell permeabilization or tissue clearing). Unlike conventional lipophilic dyes that wash out during lipid disruption, SPARKLE tags are retained and fluorescently mark the positions of LNPs. As proof of concept, we demonstrated the utility of SPARKLE tags by tracking LNPs
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.